Nanoparticulate fibrate formulations

Details for Australian Patent Application No. 2003301807 (hide)

Owner Elan Pharma International, Ltd Fournier Laboratories Ireland Ltd.

Inventors Ryde, Tuula; Ruddy, Stephen B.; Patel, Rakesh; Gustow, Evan E.; Jain, Rajeev; Wilkins, Michael John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003301807

PCT Number PCT/US2003/0145

PCT Pub. Number WO2004/041250

Priority 60/383,294 24.05.02 US; 10/370,277 21.02.03 US

Filing date 23 May 2003

Wipo publication date 7 June 2004

Acceptance publication date 25 September 2008

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/14 (2006.01) - Quaternary ammonium compounds, e.g. edrophonium, choline

A61K 31/19 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

24 June 2004 Complete Application Filed

  Priority application(s): 60/383,294 24.05.02 US; 10/370,277 21.02.03 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003301807

25 September 2008 Application Accepted

  Published as AU-B-2003301807

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003301808-Abuse-resistant opioid dosage form

2003301806-PLASMA TREATMENT MODULEEQUIPPED STERILIZATION APPARATUS AND STERILIZATION METHOD